Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2003
09/11/2003US20030170787 Isolated nucleic acid; insecticides
09/11/2003US20030170785 CDNA encoding the human alpha2 delta4 calcium channel subunit
09/11/2003US20030170783 Method to extend the life span of normal cells
09/11/2003US20030170782 Proteins
09/11/2003US20030170773 Nutritional mixture and method for early identification and count of gram-negative organisms
09/11/2003US20030170770 Enzyme activation protease assay
09/11/2003US20030170763 Protein antiallergens
09/11/2003US20030170756 Treatment of tumor cells for use in immunotherapy of cancer
09/11/2003US20030170749 Detection using antibodies; parasiticides; veterinary medicine
09/11/2003US20030170736 Adjustment of cell differentiation; medical diagnosis
09/11/2003US20030170730 Testing for drug desistance of cancer drugs
09/11/2003US20030170729 Process for the measurement of the potency of glatiramer acetate
09/11/2003US20030170721 Bonding to antibodies; genetic engineering
09/11/2003US20030170718 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170710 Quantitative analysis of adenovirus; gene therapy
09/11/2003US20030170708 Screening for mutants; primer amplification
09/11/2003US20030170704 Therapy for central nervous system disorders; Alzheimer's disease; cells transfected with Dna
09/11/2003US20030170663 Nucleotide sequence of the Mycoplasma genitalium genome, fragments thereof, and uses thereof
09/11/2003US20030170647 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
09/11/2003US20030170634 Polynucleotide encoding amylase; hydrolysis of starch
09/11/2003US20030170622 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
09/11/2003US20030170620 Gene controlling androgen
09/11/2003US20030170616 Diagnosis using antibodies; genetic engineering
09/11/2003US20030170614 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
09/11/2003US20030170274 Activation of HCV-specific T cells
09/11/2003US20030170270 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule.
09/11/2003US20030170263 Expression system
09/11/2003US20030170259 Chlamydia antigens and corresponding dna fragments and uses thereof
09/11/2003US20030170256 Coding for antigens expressed by tumor cells which may be recognized by cytotoxic T cells, leading to lysis of the tumor that express it.
09/11/2003US20030170253 Useful in stimulating angiogenesis as well as in diagnostic applications.
09/11/2003US20030170248 Constant region contains a human immunoglobulin and variable region contains a non-human immunoglobulin variable region; especially treating an infection caused by Enterohemorrhagic Escherichia coli
09/11/2003US20030170247 Methods for detection and treatment of neural cancers
09/11/2003US20030170243 Use of human plasma hyaluronidase in cancer treatment
09/11/2003US20030170238 Increasing the cytokine production of T-cells; preferably the cells are allowed to rest after harvest and then are re-activated just prior to infusion.
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170228 Compositions and methods for the treatment of tumor
09/11/2003US20030170215 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells
09/11/2003US20030170214 Method for producing a bio-artificial transplant
09/11/2003US20030170212 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
09/11/2003DE10220480C1 In vitro preparation of cells with high development potential, useful as implants for treating nerve degeneration, comprises inducing mitogen-activated protein kinase-activated protein kinase
09/10/2003EP1342795A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/10/2003EP1342786A2 DNA helicase
09/10/2003EP1342785A1 Gene hd3a inducing flowering of plant and utilization thereof
09/10/2003EP1342780A1 Improved methods for growing mammalian cells in vitro
09/10/2003EP1342779A1 Means and methods for manipulating hypersensitivity-like responses
09/10/2003EP1342729A2 Antibodies and antisense molecules for G-coupled receptor showing selective affinity for ATP
09/10/2003EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours
09/10/2003EP1342410A2 Transgenic animals lacking a functional galanin gene
09/10/2003EP1341926A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production
09/10/2003EP1341923A2 Methods for enhancing the efficacy of cancer therapy
09/10/2003EP1341921A2 Hydrolases
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341919A2 Novel human kinases and uses thereof
09/10/2003EP1341918A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/10/2003EP1341915A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue
09/10/2003EP1341905A2 Tec kinase assay
09/10/2003EP1341903A2 Plant derived hydroxy phenyl pyruvate dioxygneases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases
09/10/2003EP1341902A2 Chronic lymphocytic leukemia cell line and its use for producing an antibody
09/10/2003EP1341901A1 Method for in vitro culture of ovarian follicles
09/10/2003EP1341900A2 Method and device for producing biological tissue in a growth chamber
09/10/2003EP1341820A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof
09/10/2003EP1341818A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/10/2003EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/10/2003EP1341808A2 Synthetic nucleic acid molecule compositions and methods of preparation
09/10/2003EP1341807A2 Interferon-alpha induced gene
09/10/2003EP1341553A1 Silensed anti-cd28 antibodies and use thereof
09/10/2003EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects
09/10/2003EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
09/10/2003EP1007632A4 Isolation of bone and cartilage precursor cells
09/10/2003EP0914613B1 Dp and e2f protein nuclear localisation signals and their use
09/10/2003EP0901384B1 Polysaccharide sponges for cell culture and transplantation
09/10/2003EP0654092B1 Method for detecting pre-cancerous or cancerous cells using p90 and p53 antibodies or probes
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003EP0575546B1 Cyclin d1 and its cdna
09/10/2003CN1441843A Extracellular matrix protein
09/10/2003CN1441841A Stimulation of cellular regeneration and differentiation in inner ear
09/10/2003CN1441811A Anti-body capable to selectively detect prion PrPsc isoforms
09/10/2003CN1441810A Soluble CTL A4 mutant molecules and use thereof
09/10/2003CN1441809A Antifungal and/or antibacterial peptides, preparation methods and composition containing same
09/10/2003CN1441807A Hepatitis B core antigen fusion proteins
09/10/2003CN1441675A Compositions and methods for achieving immune suppression
09/10/2003CN1120886C Process for generating natural rooting agent by tissue culture of cape jasmine cells
09/09/2003US6617495 Nucleic acid molecules from plants coding enzymes which participate in the starch synthesis
09/09/2003US6617450 P-glycoproteins and uses thereof
09/09/2003US6617440 Isolated polynucleotide that promotes transcription; gene expression inhibition; used for engineering animals with increased lean meat and promoting muscle growth; treating muscular disorders
09/09/2003US6617433 Of given amino acid sequence; can use for gene expression
09/09/2003US6617431 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
09/09/2003US6617430 Ataxin-2 binding proteins
09/09/2003US6617428 Immunoglobulin M(IgM); given amino acid sequence; immunomodulators; use in blocking or inhibiting humoral immune responses in transplant patients
09/09/2003US6617312 Contains a sequence motif selected from the group consisting of the motifs (Asp or Glu)-Ala-Trp-(Lys or Arg) or (Tyr or Cys)-(Glu or Asp)-(Leu or Ile)-Trp; binds to vasoactive amines such as histamine
09/09/2003US6617161 Serum-free cell growth medium
09/09/2003US6617159 Serum free medium for chondrocyte cells
09/09/2003US6617158 Contacting progenitor cells ex vivo with a cytokine (transforming growth factor); use for treating anemia and other blood disorders
09/09/2003US6617145 Enzymatic protein for use in treatment of thrombosis
09/09/2003US6617135 Multiple cytokine protein complexes
09/09/2003US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer
09/09/2003US6617122 Contacting a compound with a polypeptide, in the presence of adenosine triphosphate (ATP) and detecting its binding or hydrolysis of ATP; use in treatment of coronary artery disease
09/09/2003US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent
09/09/2003US6617102 Screening for a bioactive agent capable of interfering with the binding of a protein; use in diagnosis and treatment of cancer
09/09/2003US6616925 Combined preparation for the treatment of neoplasic diseases or of infectious diseases
1 ... 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 ... 1827